Signaling network of paclitaxel-induced apoptosis in the LNCaP prostate cancer cell line

Urology

Volumn 54, Issue 4, 1999, Pages 746-752

  Panvichian, R ^b   Orth, K ^b   Pilat, M J ^b   Day, M L ^b   Day, K C ^b   Yee, C ^b   Kamradt, J M ^b   Pienta, K J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

OLOMOUCINE; PACLITAXEL; PROTEIN BCL 2; PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; DRUG CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASES; CELL CYCLE PROTEINS; CYCLIN B; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HUMANS; MALE; PACLITAXEL; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032839583     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00224-1     Document Type: Article

References (49)

1. Manfredi JJ, Parness J, and Horwitz SB: Taxol binds to cellular microtubules. J Cell Biol 94: 688-696, 1982.
2. Parness J, and Horwitz SB: Taxol binds to polymerized tubulin in vitro. J Cell Biol 91(2 Pt 1): 479-487, 1981.
3. Rao S, Krauss NE, Heerding JM, et al: 3′-(p-azidobenz-amido)Taxol photolabels the N-terminal 31 amino acids of beta-tubulin. J Biol 269: 3132-3134, 1994.
4. Schill PB, Fant J, and Horwitz SB: Promotion of microtubule assembly in vitro by Taxol. Nature 277: 665-667, 1979.
5. Schiff PB, and Horwitz SB: Taxol stabilizes microtubule assembly in vitro by Taxol. Proc Natl Acad Sci USA 77: 1561-1565, 1980.
6. Manfredi JJ, and Horwitz SB: Taxol: an antimitotic agent with a new mechanism of action. Pharmacol Ther 25: 83-125, 1984.
7. Jordan MA, Toso RJ, Thrower D, et al: Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc Natl Acad Sci USA 90: 9552-9556, 1993.
8. Jordan MA, Wendell K, Gardiner S, et al: Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56: 816-825, 1996.
9. Rudner AD, and Murray AW: The spindle assembly checkpoint. Curr Opin Cell Biol 8: 773-780, 1996.
10. Elledge SJ: Cell cycle checkpoints: preventing an identity crisis. Science 274: 1664-1672, 1996.
11. King RW, Deshaies RJ, Peters JM, et al: How proteolysis drives the cell cycle. Science 274: 1652-1659, 1996.
12. Donaldson KL, Goolsby GL, Kiener PA, et al: Activation of p34cdc2 coincident with Taxol-induced apoptosis. Cell Growth Differ 5: 1041-1050, 1994.
13. Kerr JF, Wyllie AH, and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
14. Peitsch MC, Polzar B, Stephan H, et al: Characterization of the endogenous dexoyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J 12: 371-377, 1993.
15. Bhalla K, Ibrado AM, Tourkina E, et al: Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7: 563-568, 1993.
16. Liu Y, Bhalla K, Hill C, et al: Evidence for involvement of tyrosine phosphorylation in Taxol-induced apoptosis in a human cervical tumor cell line. Biochem Pharmacol 48: 1265-1272, 1994.
17. Chinnaiyan AM, Orth K, O'Rourke K, et al: Molecular ordering of the cell death pathway: bcl-2 and bcl-xL. J Biol Chem 271: 4573-4576, 1996.
18. Ling YH, Tornos C, and Perez-Soler R: Phosphorylation of bcl-2 is a marker of M phase events and not a determinant of apoptosis. J Biol Chem 273: 18984-18991, 1998.
19. Haldar S, Jena N, and Croce CM: Inactivation of bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507-4511, 1995.
20. Haldar S, Chintapalli J, and Croce CM: Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56: 1253-1255, 1996.
21. Blagosklonny MV, Giannakakou P, el-Deiry WS, et al: raf1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res 57: 130-135, 1997.
22. Krajewski S, Tanaka S, Takayama S, et al: Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53: 4701-4714, 1993.
23. Yin DX, and Schimke RT: bcl-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res 55: 4922-4928, 1995.
24. Reed JC: bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
25. Muchmore SW, Sattler M, Liang H, et al: X-ray and NMR structure of human bcl-xL, an inhibitor of programmed cell death. Nature 381: 335-341, 1996.
26. He H, Lam M, McCormick TS, et al: Maintenance of calcium homeostasis in the endoplasmic reticulum by bcl-2. J Cell Biol 138: 1219-1228, 1997.
27. Yang J, Liu X, Bhalla K, et al: Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
28. Yang L, Guan T, and Gerace L: Integral membrane proteins of the nuclear envelope are dispersed throughout the endoplasmic reticulum during mitosis. J Cell Biol 137: 1199-1210, 1997.
29. Susin SA, Zamzami N, Castedo M, et al: bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184: 1331-1341, 1996.
30. Kluck RM, Bossy-Wetzel E, Green DR, et al: The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
31. Ito T, Deng X, Carr B, et al: bcl-2 phosphorylation re-quired for antiapoptosis function. J Biol Chem 272: 11671-11673, 1997.
32. Chang BS, Minn AJ, Muchmore SW, et al: Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J 16: 968-977, 1997.
33. Haldar S, Basu A, and Croce CM: Serine-70 is one of the critical sites for drug-induced bcl2 phosphorylation in cancer cells. Cancer Res 58: 1609-1615, 1998.
34. Salvesen GS, and Dixit VM: Caspases: intracellular signalling by proteolysis. Cell 91: 443-446, 1997.
35. Butler WB: Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle. Anal Biochem 141: 70-73, 1984.
36. Pollack A, and Ciancio G: Cell cycle phase-specific analysis of cell viability using Hoechst 33342 and propidium iodide after ethanol preservation. Anal Biochem 232: 19-24, 1995.
37. Panvichian R, Orth K, Day ML, et al: Paclitaxel-associated multimininucleation is permitted by the inhibition of caspase activation: a potential early step in drug resistance. Cancer Res 58: 4667-4672, 1998.
38. Pilat MJ, Quigley MM, Lehr JE, et al: The effects of gemcitabine and taxol on the growth of prostate cancer cells. Proc Annu Meet Am Assoc Cancer Res 39: A3994, 1998.
39. Shi L, Nishioka WK, Th'ng J, et al: Premature p34cdc2 activation required for apoptosis. Science 263: 1143-1145, 1994.
40. Meikrantz W, and Schlegel R: Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J Biol Chem 271: 10205-10209, 1996.
41. Abraham RT, Acquarone M, Andersen A, et al: Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Biol Cell 83: 105-120, 1995.
42. Vesely J, Havlicek L, Strnad M, et al: Inhibition of cyclin-dependent kinases by purine analogues. Eur J Biochem 224: 771-786, 1994.
43. Haldar S, Basu A, and Croce CM: bcl2 is the guardian of microtubule integrity. Cancer Res 57: 229-233, 1997.
44. Nigg EA: Targets of cyclin-dependent protein kinases. Curr Opin Cell Biol 5: 187-193, 1993.
45. Ibrado AM, Huang Y, Fang G, et al: bcl-xL overexpression inhibits Taxol-induced Yama protease activity and apoptosis. Cell Growth Difefr 7: 1087-1094, 1996.
46. Willingham MC, and Bhalla K: Transient mitotic phase localization of bcl-2 oncoprotein in human carcinoma cells and its possible role in prevention of apoptosis. J Histochem Cytochem 42: 441-450, 1994.
47. Marshall ICB, and Wilson KL: Trends in Cell Biological. 1997, pp 69-74.
48. Favreau C, Worman HJ, Wozniak RW, et al: Cell cycle-dependent phosphorylation of nucleoporins and nuclear pore membrane protein Gp210. Biochemistry 35: 8035-8044, 1996.
49. Shen SC, Huang TS, Jee SH, et al: Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetrodecaoylphorbol-13-acetate in human breast MCF-7 carcinoma cells. Cell Growth Diller 9: 23-29, 1998.